Sections
Edition
Language
Economy
Pharmaceuticals

The CNMC gives the green light "with commitments" to Oximesa's purchase of Esteve Teijin

Unverified translation
The Esteve tower, in Barcelona, corporate headquarters of the family pharmaceutical group
The Esteve tower, in Barcelona, corporate headquarters of the family pharmaceutical group Cedida
1 min

The National Commission for Markets and Competition (CNMC) has authorized "with commitments" the acquisition by Oximesa of the company Esteve Teijin Healthcare, after pointing out competition risks in the home respiratory therapy market in July.

The CNMC sees competition risks in Oximesa's purchase of Esteve Teijin Healthcare
The president of the National Commission on Markets and Competition, Cani Fernández, in a recent photo.
stats